Remdesivir Seems Effective Against Coronavirus, But Does It Make Gilead a Buy?

[NewsFeeder]

Remdesivir Seems Effective Against Coronavirus, But Does It Make Gilead a Buy?

Gilead Sciences (NASDAQ: GILD) released more positive results relating to remdesivir and its effectiveness in battling COVID-19 earlier this month. Let's take a closer look to see whether investors are missing out on a great opportunity here, or if remdesivir's results aren't enough to make Gilead's stock a buy. Gilead released additional data on remdesivir's effectiveness in treating COVID-19 on July 10.

https://finance.yahoo.com/m/7a55279...39d/remdesivir-seems-effective.html?.tsrc=rss

 

[Bullitt]

Market says no. Anyone remember when this was in the 80's while the floor dropped on everything else? Remdesivir trade is over.